iRhythm Holdings Inc (IRTC)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account

Sell

$110.62

Buy

$111.11

arrow-down$-3.78 (-3.30%)

Prices updated at 27 May 2026, 18:11 EDT

Prices minimum 15 mins delay

Prices in USD

iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities.

NASDAQ

-0.29%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Devices

Chairman

Mr. Abhijit Y. Talwalkar

CEO

Mr. Quentin S. Blackford

Most recent earnings

31 Dec 2025

Fiscal year end

31 Dec 2025

Employees

2,400

Head office

699 8th Street

San Francisco

United States

94103

+1 415 632-5700

investors@irhythmtech.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Jason H. Patten Independent Director	-
Mr. Abhijit Y. Talwalkar Chairman of the Board	0.12m
Ms. Karen K. McGinnis, C.P.A. Independent Director	0.03m
Mr. Bruce G. Bodaken Independent Director	0.08m
Ms. Karen L. Ling Independent Director	0.07m
Mr. Quentin S. Blackford Director, President and Chief Executive Officer	0.70m
Mr. Brian B. Yoor Independent Director	0.08m
Dr. Cathleen Noel Bairey Merz, M.D. Independent Director	0.06m
Mr. Kevin O’Boyle Independent Director	0.03m
Mr. Chad Patterson Chief Commercial Officer and Product Officer	0.50m
Ms. Sumi Shrishrimal Executive Vice President and Chief Risk Officer	-
Mr. Daniel G. Wilson Chief Financial Officer	0.45m
Mr. Patrick M. Murphy Chief Business Officer and Chief Legal Officer	0.47m
Mr. Brian Lawrence Executive Vice President and Chief Technology Officer	-
Mr. Marc Rosenbaum Senior Vice President, Finance and Chief Accounting Officer	-
Dr. Minang Turakhia, M.D.,M.S. Chief Medical Officer, Chief Scientific Officer and Executive Vice President, Advanced Technologies	0.48m
Mr. Mervin Smith Executive Vice President, Business Operations	-
Mr. Sean Clinton Freeman Executive Vice President, Strategy and Corporate Development	-
Ms. Julianne Rodda Executive Vice President and Chief People and Capability Officer	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Vanguard Group Inc	3,310,519
BlackRock Inc	2,813,989
RTW INVESTMENTS, LLC	1,668,500
Millennium Management LLC	1,608,014
Artisan Partners Limited Partnership	1,450,907

Director dealings

Date chevron-l-regular chevron-r-regular	Action
02 Dec 2025	-
28 Nov 2025	-
28 Nov 2025	-
28 Nov 2025	-
10 Nov 2025	-
10 Nov 2025	-
10 Nov 2025	-
10 Nov 2025	-
10 Nov 2025	-
10 Nov 2025	-
10 Nov 2025	-
10 Nov 2025	-
03 Nov 2025	-
31 Oct 2025	-
03 Sep 2025	-
02 Sep 2025	-
22 Aug 2025	-
11 Aug 2025	-
11 Aug 2025	-
11 Aug 2025	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.